Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
Guardado en:
Autores principales: | Florence O. Bada, Nick Blok, Evaezi Okpokoro, Saswata Dutt, Christopher Akolo, Patrick Dakum, Alash’le Abimiku |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83610cb42e904522bae86e2c4b286a7a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
por: Florence O Bada, et al.
Publicado: (2020) -
Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
por: Florence O Bada, et al.
Publicado: (2021) -
"This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis.
por: Marian Loveday, et al.
Publicado: (2021) -
Capital flows to Latin America and the Caribbean: first nine months of 2021
Publicado: (2021) -
Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study.
por: Philly O'Riordan, et al.
Publicado: (2008)